Skip to main content
Caplight Logo









Nevia Bio

Nevia Bio

Private
HaifaHealthcare & Life Scienceshttps://ginalife.com

Last Round

Seed

Aug 29, 2023

Total Funding Raised

$5M

Company Overview

Nevia Bio is a biotechnology company that develops AI-powered diagnostic platforms for the early detection of gynecological cancers, with an initial focus on ovarian cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

ovarian cancer detectionliquid biopsywomen's healthfemtechimmunoproteomicsbiomarker discoverydiagnostic assayresearch use onlyRUOlaboratory developed testLDTin-vitro diagnosticsIVDclinical diagnosticmedical AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nevia Bio Comparables

Compare Nevia Bio with similar companies based on industry and business-model similarity.

Nevia Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AOA Dx
84%
InterVenn Biosciences
77%
ClearNote Health
74%

Nevia Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 29, 2023

Nevia Bio Investors

Notable investors and investment history

Nevia Bio investors
InvestorRounds
AMIT TechnionSeed
MindUPSeed
ALIVE Israel HealthTech FundSeed

Nevia Bio Filings

Explore SEC and related filing metadata, where available.

Nevia Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nevia Bio's valuation, stock price, and market status.

Is Nevia Bio a public or private company?

Nevia Bio is a private company.

What is the current stock price of Nevia Bio?

Nevia Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Nevia Bio worth (valuation)?

Valuation information for Nevia Bio is not publicly available.

Can I buy Nevia Bio stock?

Nevia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nevia Bio's last funding round?

Nevia Bio's most recent funding round was Seed on August 29, 2023.

Who are the main investors in Nevia Bio?

Key investors in Nevia Bio include AMIT Technion, MindUP, ALIVE Israel HealthTech Fund.

Will Nevia Bio IPO soon?

No public IPO plans have been announced for Nevia Bio.

How can I track Nevia Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nevia Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHaifa
Year Founded2015
Last FundingAug 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?